go-based nanocarrier (NanoCarrier Co)
Structured Review
Go Based Nanocarrier, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/go-based+nanocarrier/go+based+nanocarrier/pm38956651-343-19-5
Average 90 stars, based on 1 article reviews
Images
Related Articles
Permeability:Article Title: Graphene oxide and flavonoids as potential inhibitors of the spike protein of SARS-CoV-2 variants and interaction between ligands: a parallel study of molecular docking and DFT Article Snippet: Studies show that the proposal of a GO-based Article Title: Biomolecular engineering for nanobio/bionanotechnology Article Snippet: The GO-based Article Title: Graphene-based hybrid composites for cancer diagnostic and therapy. Article Snippet: The development of a GO-based Article Title: Blue fluorescent graphene oxide hybrid: Synthesis, characterization, and application as a drug delivery system Article Snippet: Aminated TriPhenylAmine (A-TPA) was synthesized, and attached to the 1, 3, 5 Benzene Tricarbonyl trichloride (BT) in order to make an electron rich molecule (A-TPA-BT) and, be used for functionalization of the Graphene Oxide (GO) surface.. A comprehensive study about the properties of the functionalized GO was carried out and completed by detailed characterization techniques such as Fourier transformed infrared spectroscopy (FT-IR); UV-Vis absorption spectroscopy; Scanning Electron Microscope (SEM/EDS); X-Ray photoelectron spectroscopy (XPS); Fluorescence spectroscopy and X-ray Diffraction spectroscopy (XRD).. The synthesized A-TPA-BT compound displayed a red emission at 632 nm. Article Title: Preparation and characterization of an amylase-triggered dextrin-linked graphene oxide anticancer drug nanocarrier and its vascular permeability. Article Snippet: We synthesized a dextrin (DEX)-conjugated graphene oxide (GO) nanocarrier (GO100-DEX) as a potential drug delivery system to respond to a tumor-associated stimulus, α-amylase, that has high permeability through the fenestrated endothelial barrier to the tumor site.. At acidic pH and in the presence of α-amylase to simulate tumor conditions, GO100-DEX released a 1.5-fold higher amount of doxorubicin (DOX) than of GO100.. Under the same conditions, the cytotoxic effects of GO100-DEX/DOX were 2-fold greater than those of free DOX and 2.9-fold greater than those of GO100/DOX. |
